Cargando…

Emerging role of precision medicine in biliary tract cancers

Biliary tracts cancers (BTCs) are a diverse group of aggressive malignancies with an overall poor prognosis. Genomic characterization has uncovered many putative clinically actionable aberrations that can also facilitate the prognostication of patients. As such, comprehensive genomic profiling is pl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogenberger, James M., DeLeon, Thomas T., Arora, Mansi, Ahn, Daniel H., Borad, Mitesh J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170410/ https://www.ncbi.nlm.nih.gov/pubmed/30302397 http://dx.doi.org/10.1038/s41698-018-0064-z

Ejemplares similares

Oncolytic virotherapy in upper gastrointestinal tract cancers
por: Yokoda, Raquel, et al.
Publicado: (2018)

Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)

Applied precision cancer medicine in metastatic biliary tract cancer
por: Taghizadeh, H., et al.
Publicado: (2020)

The potential of patient-derived organoids in precision medicine of biliary tract cancer
por: Yáñez-Bartolomé, Mariana, et al.
Publicado: (2023)

Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer
por: Ferreira Martins, Nina Nayara, et al.
Publicado: (2016)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020)

Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancers
por: Okamura, Ryosuke, et al.
Publicado: (2020)

Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan
por: Kanai, Masashi
Publicado: (2022)

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
por: Harding, James J., et al.
Publicado: (2023)

The emerging role of non-radiation endoscopic management of biliary tract disorders
por: Ofosu, Andrew, et al.
Publicado: (2018)

New and emerging treatment options for biliary tract cancer
por: Noel, Marcus S, et al.
Publicado: (2013)

Genomics driven precision oncology in advanced biliary tract cancer improves survival
por: Kumar-Sinha, Chandan, et al.
Publicado: (2023)

Diagnostic Role of Bile Pigment Components in Biliary Tract Cancer
por: Ahn, Keun Soo, et al.
Publicado: (2023)

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
por: Tella, Sri Harsha, et al.
Publicado: (2023)

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
por: Yoo, Changhoon, et al.
Publicado: (2023)

The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

The Role of HER2 Status in the Biliary Tract Cancers
por: Ayasun, Ruveyda, et al.
Publicado: (2023)

Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
por: Leiting, Jennifer L., et al.
Publicado: (2020)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers
por: Zhang, Ruyi, et al.
Publicado: (2021)

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
por: Lo, Justin H., et al.
Publicado: (2023)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

Updates in Biliary Tract Cancers
por: Li, Daneng, et al.
Publicado: (2022)

Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)

The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers
por: Limb, Christopher, et al.
Publicado: (2020)

BILIARY TRACT DISORDERS
Publicado: (1984)

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
por: Ricci, Angela Dalia, et al.
Publicado: (2021)

Does radiotherapy still have a role in unresected biliary tract cancer?
por: Pollom, Erqi L., et al.
Publicado: (2016)

Molecular profile of BRCA-mutated biliary tract cancers
por: Spizzo, Gilbert, et al.
Publicado: (2020)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing()
por: Yoo, Kwai Han, et al.
Publicado: (2016)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Research Progress of Biliary Tract Cancers
por: Fonkoua, Lionel Aurelien A. Kankeu, et al.
Publicado: (2021)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_82vfg1ee4l3e1o54hqvtkdnka7